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The dIIlral characteristics and long-term survival of 284 patients
frown the Coronary Artery Surgery Study (CASS) registry data
base who hod moderate to severe congestive heart failure syrup .
tams and a left ventricular ejection fracon 20,45 were studied. A
control
gyp
consisting of registry patient, with an ejection
fraction ?0.45 who did not have heart failure was used far
comparison . Patients who had heart failure were older and more
likely to be female end to have a higher incidence of hypertension,
diabetes and chronic lung disease than registry patients who did
out have heart failure. As a ;group, patients with heart failure had
aware severe angina and were more likely to have had a prior
myocardial infarction than were registry patients without heart
fagum.
At 6 year follow-up, 82% of patients in the heart failure group
survived compared with 91 % of patients in the control group (p <
0.0001). Multivariate analysis using the Cox proportional hazards
model identified the following independent predictors of mortal-
ity: regional ventricular systolic dysfoocdon, number or diseased
coronary arteries, advanced age, hypertension, lung disease,
diabetes, ineressed left ventricular end-diastolic pressure and
heart failure, symptoms. Among patients with heart failure, the
Until recently. congestive heart failure was considered to be
primarily due to systolic dysfunction of the left ventricle . It
is now increasingly recognized that left ventricular diastolic
dysfunction is a less frequent but still common Ca:ISe of
congestive heart failure symptoms (f-6) . Transient myocar-
dial isehemia is known to cause profound alterations in !oft
ventricular relaxation (7-12) and clinically has been demon-
strated to produce severe congestive heart failure symptoms
in patients who have otherwise well preserved left ventric-
ular systolic function (10 . 13,14) . This subgroup of patients
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6-year survival rate of those who had three-vessel coronary artery
disease was 60% compared with 92% for the group without
coronary artery disease . However, the 6-year survival rate for
patients with heart failure who underwent surgical revasculariza-
tion of diseased coronary arteries was not slgntlcently improved
compared with that of patients treated medically .
It appears from the" data that the presence of moderate to
severe heart failure symptoms In patients with an ejection fraction
?0 .45 is a clinical marker for a distinct patient group character-
ized by increased age, a tore severe clinical coronary artery
disease, hypertension and an increased Incidence of additional
medical illnesses that have independent value In predicting long-
term survival . As a result of the high incidence of concurrent
Manses, this patient group has a significantly reduced 6-year
survival rate compared with a CASS registry patient group that
did not have heart failure, and the additional presence of coronary
artery disease dramatically reduces their
survival. However,
surgical treatment of coronary artery disease Is not associated
with improved survival over a (year fohbw-up period in this
CASS registry subgroup.
(J Am CaU Cardrol 1991
;18
:377-82)
remains Poorly characterized with few longitudinal
fol-
low-up data available (15).
Previous reports from the Coronary Artery Surgery
Study (CASS) (16-18) and other studies (19,20) have dem-
onstrated that patients with coronary artery disease and
reduced ejection fraction have decreased survival compared
with patients with preserved left ventricular function . For
patients with coronary disease and symptoms of congestive
heart failure despite well maintained left ventricular systolic
function . the prognosis is less clear
(15)
. Since congestive
heart failure induced
by ischemia is often reversible, it is
important to assess the impact
of medical and surgical
interventions in patients with coronary artery disease, con-
gestive heart failure and well maintained systolic function .
The CASS registry contains baseline and long-term
follow-up clinical, hemodynamic and angtogrophic data on
24,959 patients studied at 15 participating sites from 1975 to
1979
(16)
. All patients who underwent coronary angiography
for known or suspected coronary artery disease at the CASS
sites d'ning this period were included in the CASS registry
0735-109719153
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regardless of their final diagnosis or treatment . From this
registry we retrospectively defined a clinical subset of pa-
tients with significant congestive heart failure and well
preserved left ventricular systolic function and determined
their long-term survival .
The goals ofthis CASS registry analysis are twofold: 1) to
compare the clinical characteristics and long-term survival
of patients with congestive heart failure and preserved
ventricular function with those of patients without heart
failure symptoms who also underwent coronary angiogra-
phy ; and 2) to determine how the presence of coronary
artery disease additionally affects survival in patients with
heart failure and whether surgical revascularization offers a
significant survival benefit over medical treatment alone .
Methods
Patient Selection. Patients in the CASS registry with a
history of moderate to severe functional impairment from
congestive heart failure as assessed by the enrolling physi-
cian were eligible for inclusion in this study. Congestive
heart failure was considered to be present if the patient
demonstrated two or more clinical symptoms of pulmonary
congestion including orthopnea, paroxysmal nocturnal dys-
pnea and dyspnea on exertion s2 months before enrollment
in CASS . Functional impairment from heart failure was
assessed according to New York Heats Association classifi-
cation . Only patients with class III or IV symptoms were
included in this study . Physical signs of congestive heart
failure including rates, third heart sound and peripheral
edema were noted in a minority of patients chosen and these
signs were not a part of the selection criteria
. The degree of
functional impairment from angina pectoris was considered
separately from heart failure and was not one of the inclusion
or exclusion criteria for this study
.
Two hundred eighty-four patients met these criteria and
were selected for study . Patients in the registry without
symptoms of heart failure who met the exclusion ^.risen
used for the study group were included in the control broup .
The entire cohort of 13,071 patients who met the criteria was
included in the control group .
Cardiac catheteriration data . The left ventricular ejection
fraction, determined from a single-plane 45' right anterior
oblique left ventricular angiogram at study entry, was re-
quired to be >0.45. Angiogmms obtained in this standard-
ized view are the only ventriculographic data routinely
available in the CASS registry data base . An assessment of
regional wall motion was also made from the left ventricular
angiogram . Each of five cardiac segments (anterobasal,
anterolateral, apical, diaphragmatic and posterobasal) were
graded on a scale of I to 6 as follows : I = normal ; 2 =
moderately hypokinetic; 3 = severely hypokinetic ; 4 =
akinetic ; 5 = dyskinetic ; 6 = aneurysmal . The sum of the
scores for each region is hereafter referred to as the left
ventricular score . Thus, a score of 5 represents completely
normal left ventricular systolic function . Patients with mod-
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erase to severe initial regurgitation, prior card . : c surgery,
left main coronary artery disease or left ventricular aneu-
rysm were excluded from analysis .
The number of diseased vessels in individual patients was
determined by coronary angiography in the following man-
ner. Stenosis >_70% in either the proximal or the distal
portion of any of the three major coronary vessels was
required by the CASS to classify a vessel as diseased .
Patients with left main stenosis w50% were excluded from
further analysis in this study . In the case of left coronary
dominance a diseased circumflex artery was classified two-
vessel disease . For the purpose of this study no distinction
was made between proximal and distal lesions . In other
words, a 701/c stenosis in the left anterior descending artery
was classified as a single diseased vessel whether the steno-
sis occurred proximal to the first septal perforator or in the
mid or distal portion of the artery .
Statistical methods . Comparisons of clinical characteris-
tics between the two groups were performed with use of the
chi-square and Student's t tests for categoric and continuous
variables, respectively . Survival functions were computed
with use of the Kaplan-Meier method and statistical compar-
isons between groups were made with use of the log-rank
statistic . A p value <0.05 is considered statistically signifi-
cant ; all p values are two-sided
. Adjustments for differences
in baseline variables were made with use of the Cox propor-
tional hazards model . A stepwise procedure was used to
screen the baseline factors that were significantly associated
with mortality and then an adjusted p value was calculated in
the model with use of those factors .
Results
Clinical Characteristics
Clinical features (Table 1) . The clinical characteristics of
both the study and the control group at entry into the CASS
registry are summarized in Table 1 . The two groups differ
markedly across a wide range of clinical variables . Patients
with congestive heart failure are older (56 vs . 52 years,
p < 0
.0001) and are more likely to be female (44% vs. 26%,
p < 0
.0001) than are patients without heart failure . Study
patients also have a higher incidence of hypertension
(p = 0
.0003), diabetes (p < 0.0001) and chronic lung disease
(p < 0 .0001) . The incidence of smoking (40% vs . 35%,
p = 0.06) and hypercholesterolemia (232 vs. 238 mg(dl) did
not differ significantly between patients in the heart failure
and nonheart failure groups . Canadian Cardiovascular Soci-
ety class III or IV angina severity was present in 70% of the
patients with heart failure compared with 43% of those
without heart failure (p < 0.0001) . Patients with heart failure
were also more likely to have had a prior myocardial
infarction (53% Vs.
38%, p < 0
.0001)
. The differential use of
nitrates (75% vs. 61%, p < 0.0001) was
higher
in the heart
failure group. However, the use of beta-adrenergic blocking
agents (46% vs . 47%) was not significantly different . The use
UACC YSII, 18, No. 2
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Table L Baseline Clinical Comparisons Between Groups With
	
Table 2 . Catheteaation Data
and Without Congestive Heaf Failure (CHF(
Figure I- Overall survival by congestive heart failure
(CHF) status . The 6year survival of CASK registry
patients with an ejection fraction 00.45 and congest
heart failure (Iriangha) la compared wish chat of re8is-
try patients with en ejrrtion Fraulioo x0,45 with, vL
congestive heart failure (circksl (p < 0
.00011 .
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vs
. 18%, p < 0
.0001) was predictably higher in the heart
failure group
.
Cardiac catheterization (Table 21. The average number of
diseased vessels was not different between patients to the
heart failure and nonheart failure groups (L4 -_ 1 .2 in both
groups) . The proportion of patients with name, one-, two- or
three-vessel coronary artery disease was not significantly
different between the two groups : however, slightly more
patients without heart failure had three-vessel disease . One-
third of aft patients in the CASS registry demonstrated either
normal coronary arteries or angiographically insignificant
lesions, The group without heart failure symptoms demon-
strated a slightly higher average ejection fraction than that of
'Ill do-ware test . CAD = w,00uey anew disease ; CHF= congestive
heart failure : LV EDP = left ventneuhr end-diastolic pressure
; LVSCOR is a
conipnstle arsa;urclneM of regrenal avstolic funclsoe 50015 motion) leaned
Coitus in the Metha v section
.
the study group (0 .65 vs. 0.62, p < 0
.0001). The control
group also had fewer segmental wall motion abnormalities
(mean left ventricular score 6 .3 compared with 7.0 for the
heart failure group, p < 0 .0001) and a lower mean left
ventricular end-diastolic pressure (11 .2 ± 5 .6 vs- 12 .4 ± 7.2,
p < 0.001). Thus, all indexes
of left ventricular Function
examined in this study were signfficanlly better
in the control
group than in the heart failure group, despite the selection of
patients with an ejection fraction 20 .45 for both groups .
Although the patients with heart failure had relatively pre-
served global systolic function . significant abnormalities in
regional function were noted in comparison with findings in
the control patients .
Survival
A comparison of survival in the two groups is shown in
Figure L After 6 years, 82% of patients in The heart failure
group were alive compared with 91% of patients in the
control group (p < 0-0001) .
Variabiespredictiveofmortality (Table 3). Stepwisemul-
tiple regression analysis using the Coy. proportional hazards
model was perfumed for the combined study and control
groups . The left ventricular score, the composite score for
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Table J. Independent Predictor, of yortality Istepwise
multiple regression)
'Peripheral vascular disease, renal disease or cerebrovascular diseam . or
combinnfmns. Ahbrcvintinru .,,a Table t.
segmental wail motion abnormalities, was the strongest
independent predictor of mortality (chi-square (A) = 102 .4) .
Therefore, despite the selection of patients with an ejection
fraction >_0 .45, the degree to which systolic dysfunction is
present remains the single best predictor of outcome . Addi-
tional independent predictors of mortality include the num-
ber of diseased vessels (,r = 87.8)1, patient age (92 = 71 .3),
hypertension (a^ = 33 .2), chronic lung disease (i = 17 .7) .
diabetes (9 = 13 .8) and left ventricular end-diastolic pres-
sure (,2 = 6 .9) . The presence of other illnesses including
renal disease, peripheral vasculardisease and cercl7rovascu-
tar disease, alone or in combination, provided additional
independent predictive value for mortality .
Role of congestive heart faanre, The presence of moder-
ate to severe impairment from congestive heart failure was a
significant univariate predictor of mortality (yn = 22 .68) in
this study. However, after the stepwise multivariate analy-
sis, the importance of congestive heart failure as an indepen-
dent predictor of outcome was reduced to marginal signifi-
cance (92 = 3,78, p = 0.05) . 11iis analysis suggests that
although the presence of heart failure in a CA5S registry
patient with preserved systolic function is associated with a
decreased (,-year survival rate, it is the presence of associ-
ated clinical features and illnesses rather than the heart
failure itself that primmily accounts for the decreased mor-
tality. Nonetheless, in CASS registry patients the presence
of heart failure appears to be an important and convenient
marker for decreased long-term survival even among pa-
tients with preserved global systolic function .
R9k of eoronnry notary disease severity. The effect of
coronary artery disease an the long-term survival of registry
patients with heart failure was also examined, The survival
curves for patients with heart failure without coronary
disease were compared with survival curves for patients
with one- or two-vessel disease and for those with three-
vessel coronary disease (Fig . 2) . Patients without coronary
disease had a 6-year survival rate of 92%, compared with
93% in patients with one- or two-vessel disease and 68%
(p = 0,0001) in patients with three-vessel disease . Thus, in
patients with preserved systolic function and heart failure,
the severity of underlying coronary disease has a signifiant
impact on long-term survival .
Role of surgical rerascularintion . Despite the important
role of coronary ~!rtery disease in predicting adverse out-
comes in patients with heart failure and preserved systolic
function, surgical coronary revascularization did not confer
a statistically significant survival advantage in this group by
multivariate analysis (p = 0.26) . However, only a small
number of patients were available in the study subset for
comparison of results of medical and surgical treatment (n -
154) and only a small number of patients in the CASS
registry data base were included in the randomized trial (17).
Therefore, the role of surgical revasculaeiration in the treat-
ment of patients with coronary artery disease, symptoms of
heart failure and preserved systolic function cannot be
rigorously assessed from the CASS registry data base .
Discussion
Role of mynrardial ischewta. Reports of patients present-
ing with congestive heart failure symptoms and normal
systolic function have appeared sporadically over the last 20
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Figure 2 . The impact of severity of coronary artery
disease on the survivalof CASS registry patients with
congestive heart failure and an ejection fraction
?0.45 . Six-year survival curves are shown for regis-
try patients with no significant coronary disease (dr
eks), patients with ane- and two-vessel coronary
disease (filled triangles) and patients with three-vessel
coronary disease (open triangles) (p < 0 .0001)
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years (I-5 .10,13,14) . In recent reported series in patients
with coronary artery disease (7-9 .11,12), atrial pacing has
been shown to produce marked changes in regional systolic
function in association with significant increases in left
ventrteutar end-diastolic pressure . More recently, in re-
ported series of patients (1-4) with the diagnosis of conges-
tive heart failure referred for radionuclide angiography or
echocardiography, as many as 42% have had an ejection
fraction >0.45 . A consistent clinical feature in these patients
is
the presence of hypertension or coronary disease .  or both .
Among patients with coronary disease and normal sys-
tolic function who present with pulmonary edema . reversible
myocardial ischemia is frequently the precipitating event
(13,14) . In patients with coronary disease, atrial pacing has
been shown to produce marked changes in regional systolic
function in association with significant increases in left
ventricular end-diastolic pressure (7-9 .11,12), Considerable
evidence supports the existence of painless myocardial
ischemia (21,22) . Given the demonstrated impact of ischemia
on left ventricular end-diastolic pressure it is not surprising
that myocardial ischemia can indeed manifest itself in many
instances as severe dyspnea with or without concurrent
angina, The clinical characteristics of patients with this form
of symptomatic coronary disease and preserved systolic
ventricular function have not been completely documented.
Whether the presence of heart failure symptoms in the
absence of significantly depressed ventricular systolic func-
tion confers an increased mortality risk is not clear .
The current CASS registry study suggests that patients
referred for angiography with suspected coronary artery
disease and significant congestive heart failure symptoms in
the absence of global left ventricular dysfunction are in fact
quite different from patients without clinical heart failure .
Patients with heart failure are more likely to be female and
older and to have more associated inedical illnesses includ-
ing hypertension, diabetes and chronic lung disease . In
addition, despite having the same number of diseased ves-
sels at angiography, they have more severe angina, are more
likely to have had a prior myocardial infarction and have
significantly more ventricular wall motion abnormalities .
Therefore, despite an equivalent number of diseased vessels,
the patients with congestive heart failure in this study have
had a more active clinical course than have the patients
without heart failure.
Effects of concurrent illnesses on survival . The CASS
registry patients with congestive heart failure have a signif-
icantly higher mortality rate over a 6-year follow-up period
than that of registry patients without failure. Stepwise mul-
tiple regression analysis revealed that the higher mortality
was largely accounted far by the presence of additional
significant covariates, including segmental wall motion ab-
normalities, hypertension, the number of diseased vessels,
age, diabetes and chronic lung disease. Therefore, the pres-
ence of heart failure appears to be a useful marker for a
patient with an adverse prognosis despite well preserved
systolic function . Given the number of important covariates
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associated with the presence of heart failure in determining
prognosis, the mechanism by which heart failure occurs in
these patients is not likely to be due to a single cause .
Hypertension (5 .23,24), previous myocardial infarction (25)
and increased age (26,27) have all been demonstrated to be
associated with altered patterns of left ventricular diastolic
filling.
Barrow et al. (28) demonstrated a high incidence of
abnormal diastolic left ventricular filling patterns in patients
with coronary artery disease who have entirely normal
systolic function . Transient, reversible myocardial ischemia
can also dramatically decrease left ventricular compliance to
the point of causing pulmonary congestion . This effect is
likely to he must severe in patients who have baseline
abnormalities in diastolic function (for example, in patients
with left ventricular hypertrophy due to hypertension or
patients with prior myocardial infarction). Specific data
regarding left ventricular filling patterns and left ventricular
compliance are not available in the CASS registry . By
inference . however, it is likely that significant abnormalities
in diastolic function are present in this study's elderly,
hypertensive patients with advanced coronary artery dis-
ease .
Impact of coronary artery disease on survival . The pres-
ence of coronary artery disease had a particularly marked
effect on survival in patients with heart failure and preserved
systolic ventricular function in the current study . Ninety-
two percent of the patients who had heart failure without
coronary artery disease were alive at 6 years in contrast to
only 68% of the patients with three-vessel disease .
A recent report (29) from the V-HeFT study documented
the 5-year survival of patients with heart failure, cardiac
enlargement and an ejection fraction x0.45 . The investiga-
tors compared findings in 83 patients with heart failure and
an ejection fraction ?0 .45 with those in 540 patients with an
ejection fraction <0 .45. The former group had a higher
incidence of hypertension but a lower incidence of coronary
artery disease and an annual mortality rate of 8% compared
with 19l for the low ejection fraction group . Although the
present CASS study and the V-HeFT study are drawn from
dissimilar patient groups, the greater age and increased
incide nee of hypertension among patients with heart failure
symptoms and preserved systolic function are observed in
both studies . Previous observational studies (1-5) have also
demonstrated an association between hypertension and pu-
tative abnormalities in diastolic function. However, as dem-
onstrated in the current study, the additional presence of
coronary artery disease dramatically reduces survival rates .
Effect of revascularizatian on survival . Given the signifi-
cant impact of coronary artery disease on survival of pa-
tients in the study group, the results of surgical revascular-
ization were of particular interest
. Multivariate analysis
failed to show a statistically significant benefit to long-term
survival associated with surgical treatment in this study
group . The negative result obtained must be cautiously
considered given the small number of patients available for
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comparison and the retrospective nature of the analysis .
Previous CASS reports, including the randomized trial (17),
have also failed to show
a survival advantage for surgical
revoscularieatian over medical treatment alone among pa-
tients with intact left ventricular systolic function . except in
those wish left main coronary artery disease . A previous
CASS registry study (]D) of patients with severe angina and
threc-vessel disease . however. demonstrated an improved
6-year survival rate with surgical treatment. Seventy percent
of the patients in the present study had Canadian Cardiovas-
cular Society class III or I V angina
. On this basis a reason-
able clinical argument could be made for s-crgical revascu-
larizalion in patients with multivessel coronary disease and
severe angina, heart failure and preserved
Sys(olic VenIricu-
larfunetion . Whether coronary revasculadzalier procedures
including coronary angioplasty, would improve survival is
not yet known. As the median age ofthe general Population
continues to rise, an increasing number of patients with heart
failure symptoms, advanced coronary disease and preserved
systolic function will likely be seen . The appropriate man-
agement of there patients will require careful consideration
of the concurrent physiologic abnormalities that predispose
them to reduced long-term survival .
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